(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and last week and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Roquefort Therapeutics PLC on Monday said it entered into heads of terms to buy Coiled Therapeutics Inc, also known as Coiled USA, via a reverse takeover. Read More
(Alliance News) - Roquefort Therapeutics PLC on Thursday said it has further extended the deadline for completing a deal for the sale of subsidiary Lyramid Pty Ltd, and has also incorporated a new equity holding company. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Roquefort Therapeutics PLC on Monday said it has agreed the terms for the proposed sale of its wholly-owned subsidiary Oncogeni Ltd to UAE-based conglomerate Nations Trust Holding LLC, for up to USD12 million. Read More
(Alliance News) - Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma Ltd for a minimum of USD10 million. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approved by the Japan Patent Office. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
